A New Drug Delivery System Based on Tauroursodeoxycholic Acid and PEDOT.
Stefano CarliGiulia FioravantiAndrea ArmirottiFrancesca CiarpellaMirko PratoGiuliana OttonelloMarco SalernoAlice ScarpelliniDaniela PerroneElena MarchesiDavide RicciLuciano FadigaPublished in: Chemistry (Weinheim an der Bergstrasse, Germany) (2019)
Localized drug delivery represents one of the most challenging uses of systems based on conductive polymer films. Typically, anionic drugs are incorporated within conductive polymers through electrostatic interaction with the positively charged polymer. Following this approach, the synthetic glucocorticoid dexamethasone phosphate is often delivered from neural probes to reduce the inflammation of the surrounding tissue. In light of the recent literature on the neuroprotective and anti-inflammatory properties of tauroursodeoxycholic acid (TUDCA), for the first time, this natural bile acid was incorporated within poly(3,4-ethylenedioxythiophene) (PEDOT). The new material, PEDOT-TUDCA, efficiently promoted an electrochemically controlled delivery of the drug, while preserving optimal electrochemical properties. Moreover, the low cytotoxicity observed with viability assays, makes PEDOT-TUDCA a good candidate for prolonging the time span of chronic neural recording brain implants.
Keyphrases
- drug delivery
- perovskite solar cells
- anti inflammatory
- systematic review
- oxidative stress
- cerebral ischemia
- small molecule
- reduced graphene oxide
- high throughput
- low dose
- white matter
- resting state
- high dose
- room temperature
- functional connectivity
- emergency department
- photodynamic therapy
- single molecule
- molecularly imprinted
- blood brain barrier
- high resolution